↓ Skip to main content

Evaluation of adjuvants for protein vaccines against tuberculosis in guinea pigs

Overview of attention for article published in Vaccine, February 2003
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (78th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

patent
3 patents

Readers on

mendeley
22 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Evaluation of adjuvants for protein vaccines against tuberculosis in guinea pigs
Published in
Vaccine, February 2003
DOI 10.1016/s0264-410x(02)00548-0
Pubmed ID
Authors
Abstract

Subunit vaccines against tuberculosis show promise but require administration with adjuvants to stimulate relevant immune responses for protection. Guinea pigs are the model of choice for evaluating protective immunity to aerogenic challenge with virulent mycobacteria, but few studies have been undertaken to identify suitable adjuvants for vaccine screening in this species. Here, we compare the efficacy of several adjuvants to induce T cell responses to culture filtrate protein in guinea pigs. We report that of several adjuvants tested, the most promising was CpG ODN formulated in an aqueous emulsion. This adjuvant induced type 1 T cell responses equivalent to that of FIA, as measured by delayed-type hypersensitivity reactions (DTH), antigen-specific T cell proliferation and antigen-specific IgG1 and IgG2 responses. These data demonstrate the potential for CpG motif based adjuvants for use in TB vaccine screening in guinea pigs, and other diseases where a type 1 T cell response is required.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 6 27%
Student > Doctoral Student 2 9%
Student > Bachelor 2 9%
Student > Ph. D. Student 2 9%
Lecturer > Senior Lecturer 1 5%
Other 3 14%
Unknown 6 27%
Readers by discipline
Readers by discipline Count As %
Agricultural and Biological Sciences 6 27%
Medicine and Dentistry 4 18%
Biochemistry, Genetics and Molecular Biology 2 9%
Immunology and Microbiology 2 9%
Social Sciences 1 5%
Other 0 0%
Unknown 7 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 June 2014.
All research outputs
#6,780,480
of 31,542,270 outputs
Outputs from Vaccine
#6,833
of 18,901 outputs
Outputs of similar age
#22,416
of 183,119 outputs
Outputs of similar age from Vaccine
#45
of 119 outputs
Altmetric has tracked 31,542,270 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 18,901 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 18.9. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 183,119 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 119 others from the same source and published within six weeks on either side of this one. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.